The Mechanisms of Action of Intravenous Immunoglobulin and Polyclonal Anti-D Immunoglobulin in the Amelioration of Immune Thrombocytopenic Purpura: What Do We Really Know?
- 30 April 2008
- journal article
- review article
- Published by Elsevier BV in Transfusion Medicine Reviews
- Vol. 22 (2), 103-116
- https://doi.org/10.1016/j.tmrv.2007.12.001
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Intravenous immunoglobulins suppress T-cell priming by modulating the bidirectional interaction between dendritic cells and natural killer cellsBlood, 2007
- Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopeniaBlood, 2006
- T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpuraNature Medicine, 2003
- Immune thrombocytopenia and Fc receptor-mediated phagocyte functionAnnals of Hematology, 1994
- IgG Induction of IL‐1 Receptor Antagonist Production by Human MonocytesImmunological Reviews, 1994
- A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-DThe Journal of Pediatrics, 1992
- Treatment of acute idiopathic thrombocytopenic purpura of childhood with intravenous immunoglobulin G: Comparative efficacy of 7S and 5S preparationsThe Journal of Pediatrics, 1986
- Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor AntibodyNew England Journal of Medicine, 1986
- Fc-depleted vs intact intravenous immunoglobulin in chronic ITPThe Journal of Pediatrics, 1984
- Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1982